Podcasts | pharmaphorum

Patients

CinCor Pharma: A small pharma’s journey to acquisition

In this week's podcast, pharmaphorum welcomes Marc de Garidel, CEO of CinCor Pharma.

Digital

AI trends in 2023

AI in pharma is trending toward a moment of maturity, reliability, and scalability.

Digital

Accelerating digital healthcare, with VITA

Last month, pharmaphorum travelled to Rome to cover the inaugural VITA Accelerator demo day.

Sales & Marketing

Investing in healthcare futures: Elia Stupka and Paul Tunnah

Angelini Ventures is an new investment fund seeking companies transformational in healthcare.

Digital

Solving problems in pathology data, with Nathan Buchbinder

Jonah Comstock chats with Nathan Buchbinder, co-founder and chief product officer at Proscia.

Patients

How Moderna kept diversity in mind amid vaccine development

In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.

Digital

Key themes from JP Morgan, with Paul Tunnah – the pharmaphor...

This week, pharmaphorum editor-in-chief Jonah Comstock and pharmaphorum founder Paul Tunnah headed to San Francisco for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bi

Oncology

Cancer control in a time of crisis - the pharmaphorum podcas...

During The Economist’s 8th Annual World Cancer Series congress in Brussels November last year, web editor Nicole Raleigh sat down to discuss the event and its themes with

Sales & Marketing

Investing in healthcare futures: Elia Stupka and Paul Tunnah

Angelini Ventures is an new investment fund seeking companies transformational in healthcare.

Sales & Marketing

The scattered seeds of the beginnings of change - a pharmaph...

Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and

Digital

AI trends in 2023

AI in pharma is trending toward a moment of maturity, reliability, and scalability.

Digital

Accelerating digital healthcare, with VITA

Last month, pharmaphorum travelled to Rome to cover the inaugural VITA Accelerator demo day.

Market Access

Exploring a united vision for British pharma at Anthropy - t...

Anthropy 2022 brought climate change to industry in Cornwall in (a very wet and windy) early November, settling cosily into the truly eco-minded environs of the Eden Proje

Market Access

Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaph...

Episode 35 of the pharmaphorum podcast hears from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit. With RNA-based technology hitti

Oncology

Cancer control in a time of crisis - the pharmaphorum podcas...

During The Economist’s 8th Annual World Cancer Series congress in Brussels November last year, web editor Nicole Raleigh sat down to discuss the event and its themes with

Oncology

Understanding the tumour micro-environment – the pharmaphoru...

As our understanding of oncology has increased, it’s become clear that each cancer consists of much more than just the tumour cell – a whole ecosystem of vessels, immune cells, and connective tissu

Oncology